Jefferies initiates coverage on Oncothyreon (NASDAQ: ONTY) with a Buy rating and a price target of $2.50, suggesting 49% upside ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE